跳至主要内容
临床试验/NL-OMON25641
NL-OMON25641招募中不适用

Correlating plasma nintedanib concentrations with clinical outcome and toxicity in patients with interstitial lung disease

Erasmus MC dept. of Medical Oncology and dept. of Pulmonology0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age 18 years or older;
  • Able to understand the written Information and able to give informed consent;
  • Planned treatment with nintedanib for any fibrotic ILD according to standard of care.

排除标准

  • A potential subject who is unable to draw blood for study purposes will be excluded.

研究者

发起方
Erasmus MC dept. of Medical Oncology and dept. of Pulmonology

相似试验